Plasma amyloid-β levels in drug-resistant bipolar depressed patients receiving electroconvulsive therapy. 2013

Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. a.piccinni@med.unipi.it

OBJECTIVE Alterations of plasma amyloid-β (Aβ) peptides have been related to a high risk for cognitive impairment and dementia. The present study aimed to measure plasma Aβ peptides (Aβ40, Aβ42) and the Aβ40/Aβ42 ratio in a sample of drug-resistant bipolar depressed patients, as well as to explore the possible correlation between biological parameters and clinical changes along an electroconvulsive therapy (ECT) course. METHODS Aβ40 and Aβ42 were measured by means of an ELISA assay in 25 drug-resistant bipolar depressed patients before (T0) and 1 week after (T1) the end of ECT. The patients were clinically evaluated by means of the Hamilton Rating Scale for Depression, 21-item (HRSD-21), the Mini-Mental State Examination, and the Clinical Global Impressions-Severity of Illness Scale. RESULTS Plasma Aβ levels and the Aβ40/Aβ42 ratio were similar at T0 and T1. The Aβ40/Aβ42 ratio correlated positively with the HRSD total score at both T0 and T1. At T0, a negative correlation was found between the Aβ40/Aβ42 ratio and the improvement of depressive and cognitive symptoms. Moreover, remitters (n = 9; HRSD ≤10) showed a significantly lower Aβ40/Aβ42 ratio at T0 than nonremitters. CONCLUSIONS The present data suggest that a low Aβ40/Aβ42 ratio might characterize a subgroup of depressed patients who respond to ECT, while higher values of this parameter seem to be typical of more severe cases of patients with cognitive impairment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
October 1990, Journal of clinical psychopharmacology,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
January 1989, Convulsive therapy,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
January 1983, Comprehensive psychiatry,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
January 2018, Neuropsychiatric disease and treatment,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
December 2006, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
August 1988, Biological psychiatry,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
March 2022, Journal of neural transmission (Vienna, Austria : 1996),
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
May 2015, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
December 2005, Psychiatry research,
Armando Piccinni, and Antonello Veltri, and Chiara Vizzaccaro, and Mario Catena Dell'Osso, and Pierpaolo Medda, and Luciano Domenici, and Federica Vanelli, and Marta Cecchini, and Caterina Franceschini, and Ciro Conversano, and Donatella Marazziti, and Liliana Dell'Osso
September 2019, The journal of ECT,
Copied contents to your clipboard!